Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

Details for Australian Patent Application No. 2002228887 (hide)

Owner United States Army Medical Research and Material Command

Inventors Jensen, Melody; Smith, Leonard A.

Agent Davies Collison Cave

Pub. Number AU-B-2002228887

PCT Pub. Number WO02/36758

Priority 09/910,186 20.07.01 US; 60/246,774 06.11.00 US; 60/311,966 09.08.01 US

Filing date 6 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 24 August 2006

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

24 August 2006 Application Accepted

  Published as AU-B-2002228887

21 December 2006 Standard Patent Sealed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228888

2002228886-Interferons, uses and compositions related thereto